Review




Structured Review

Sanofi red fluorescent protein rfp
Red Fluorescent Protein Rfp, supplied by Sanofi, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/red+fluorescent+protein+rfp/fluorescent+protein+red+rfp/pmc13006415-484-22-27
Average 86 stars, based on 1 article reviews
red fluorescent protein rfp - by Bioz Stars, 2026-09
86/100 stars

Images

Related Articles

In Vitro:

Article Title: Targeting BCMA in multiple myeloma with a trifunctional NK cell engager
Article Snippet: .. For the in vitro cytokine release assay, RPMI 8226-RFP cells were derived from RPMI 8226 cells obtained from ATCC and transfected with red fluorescent protein (RFP) by Sanofi. .. The modified RPMI 8226-RFP cells were cultured in RPMI 1640 (Thermo Fisher Scientific, Inc., Waltham, MA, USA) supplemented with 10% FBS (Thermo Fisher Scientific, Inc.) and 1% Penicillin-Streptomycin (10,000 U/mL, Thermo Fisher Scientific, Inc.) at 37°C in a humidified atmosphere of 5% CO 2 .

Article Title: Targeting BCMA in multiple myeloma with a trifunctional NK cell engager.
Article Snippet: .. For the in vitro cytokine release assay, RPMI 8226-RFP cells were derived from RPMI 8226 cells obtained from ATCC and transfected with red fluorescent protein (RFP) by Sanofi. .. The modified RPMI 8226-RFP cells were cultured in RPMI 1640 (Thermo Fisher Scientific, Inc., Waltham, MA, USA) supplemented with 10% FBS (Thermo Fisher Scientific, Inc.) and 1% Penicillin-Streptomycin (10,000 U/mL, Thermo Fisher Scientific, Inc.) at 37◦C in a humidified atmosphere of 5% CO2.

Release Assay:

Article Title: Targeting BCMA in multiple myeloma with a trifunctional NK cell engager
Article Snippet: .. For the in vitro cytokine release assay, RPMI 8226-RFP cells were derived from RPMI 8226 cells obtained from ATCC and transfected with red fluorescent protein (RFP) by Sanofi. .. The modified RPMI 8226-RFP cells were cultured in RPMI 1640 (Thermo Fisher Scientific, Inc., Waltham, MA, USA) supplemented with 10% FBS (Thermo Fisher Scientific, Inc.) and 1% Penicillin-Streptomycin (10,000 U/mL, Thermo Fisher Scientific, Inc.) at 37°C in a humidified atmosphere of 5% CO 2 .

Article Title: Targeting BCMA in multiple myeloma with a trifunctional NK cell engager.
Article Snippet: .. For the in vitro cytokine release assay, RPMI 8226-RFP cells were derived from RPMI 8226 cells obtained from ATCC and transfected with red fluorescent protein (RFP) by Sanofi. .. The modified RPMI 8226-RFP cells were cultured in RPMI 1640 (Thermo Fisher Scientific, Inc., Waltham, MA, USA) supplemented with 10% FBS (Thermo Fisher Scientific, Inc.) and 1% Penicillin-Streptomycin (10,000 U/mL, Thermo Fisher Scientific, Inc.) at 37◦C in a humidified atmosphere of 5% CO2.

Derivative Assay:

Article Title: Targeting BCMA in multiple myeloma with a trifunctional NK cell engager
Article Snippet: .. For the in vitro cytokine release assay, RPMI 8226-RFP cells were derived from RPMI 8226 cells obtained from ATCC and transfected with red fluorescent protein (RFP) by Sanofi. .. The modified RPMI 8226-RFP cells were cultured in RPMI 1640 (Thermo Fisher Scientific, Inc., Waltham, MA, USA) supplemented with 10% FBS (Thermo Fisher Scientific, Inc.) and 1% Penicillin-Streptomycin (10,000 U/mL, Thermo Fisher Scientific, Inc.) at 37°C in a humidified atmosphere of 5% CO 2 .

Article Title: Targeting BCMA in multiple myeloma with a trifunctional NK cell engager.
Article Snippet: .. For the in vitro cytokine release assay, RPMI 8226-RFP cells were derived from RPMI 8226 cells obtained from ATCC and transfected with red fluorescent protein (RFP) by Sanofi. .. The modified RPMI 8226-RFP cells were cultured in RPMI 1640 (Thermo Fisher Scientific, Inc., Waltham, MA, USA) supplemented with 10% FBS (Thermo Fisher Scientific, Inc.) and 1% Penicillin-Streptomycin (10,000 U/mL, Thermo Fisher Scientific, Inc.) at 37◦C in a humidified atmosphere of 5% CO2.

Transfection:

Article Title: Targeting BCMA in multiple myeloma with a trifunctional NK cell engager
Article Snippet: .. For the in vitro cytokine release assay, RPMI 8226-RFP cells were derived from RPMI 8226 cells obtained from ATCC and transfected with red fluorescent protein (RFP) by Sanofi. .. The modified RPMI 8226-RFP cells were cultured in RPMI 1640 (Thermo Fisher Scientific, Inc., Waltham, MA, USA) supplemented with 10% FBS (Thermo Fisher Scientific, Inc.) and 1% Penicillin-Streptomycin (10,000 U/mL, Thermo Fisher Scientific, Inc.) at 37°C in a humidified atmosphere of 5% CO 2 .

Article Title: Targeting BCMA in multiple myeloma with a trifunctional NK cell engager.
Article Snippet: .. For the in vitro cytokine release assay, RPMI 8226-RFP cells were derived from RPMI 8226 cells obtained from ATCC and transfected with red fluorescent protein (RFP) by Sanofi. .. The modified RPMI 8226-RFP cells were cultured in RPMI 1640 (Thermo Fisher Scientific, Inc., Waltham, MA, USA) supplemented with 10% FBS (Thermo Fisher Scientific, Inc.) and 1% Penicillin-Streptomycin (10,000 U/mL, Thermo Fisher Scientific, Inc.) at 37◦C in a humidified atmosphere of 5% CO2.



Similar Products

95
Angio-Proteomie red fluorescent protein rfp human umbilical vein endothelial cells huvecs
Sketch of a tooth injury where the highly vascularized dental pulp is exposed. Angiogenesis in the dental pulp is emulated on a three-channel microfluidic chip where dental pulp stem cells are seeded in fibrin hydrogel in the middle. <t>HUVECs</t> are seeded on the gel interface in the side channel, forming a monolayer that is sprouting into the gel. Here, the model is used for evaluating dentistry-related drugs and biomaterials.
Red Fluorescent Protein Rfp Human Umbilical Vein Endothelial Cells Huvecs, supplied by Angio-Proteomie, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/red+fluorescent+protein+rfp/Human+Umbilical+Vein+Endothelial+Cells/pmc12830287-260-0-10
Average 95 stars, based on 1 article reviews
red fluorescent protein rfp human umbilical vein endothelial cells huvecs - by Bioz Stars, 2026-09
95/100 stars
  Buy from Supplier

86
Sanofi red fluorescent protein rfp
Sketch of a tooth injury where the highly vascularized dental pulp is exposed. Angiogenesis in the dental pulp is emulated on a three-channel microfluidic chip where dental pulp stem cells are seeded in fibrin hydrogel in the middle. <t>HUVECs</t> are seeded on the gel interface in the side channel, forming a monolayer that is sprouting into the gel. Here, the model is used for evaluating dentistry-related drugs and biomaterials.
Red Fluorescent Protein Rfp, supplied by Sanofi, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/red+fluorescent+protein+rfp/fluorescent+protein+red+rfp/pmc13006415-484-22-27
Average 86 stars, based on 1 article reviews
red fluorescent protein rfp - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier

92
Rockland Immunochemicals fluorescent protein detection
Sketch of a tooth injury where the highly vascularized dental pulp is exposed. Angiogenesis in the dental pulp is emulated on a three-channel microfluidic chip where dental pulp stem cells are seeded in fibrin hydrogel in the middle. <t>HUVECs</t> are seeded on the gel interface in the side channel, forming a monolayer that is sprouting into the gel. Here, the model is used for evaluating dentistry-related drugs and biomaterials.
Fluorescent Protein Detection, supplied by Rockland Immunochemicals, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/red+fluorescent+protein+rfp/Recombinant+Red+Fluorescent+Protein+(RFP)+Control/bio_rxiv__64898__2026__03__04__709430-241-5-11
Average 92 stars, based on 1 article reviews
fluorescent protein detection - by Bioz Stars, 2026-09
92/100 stars
  Buy from Supplier

98
Rockland Immunochemicals antibody against red fluorescence protein rfp
Sketch of a tooth injury where the highly vascularized dental pulp is exposed. Angiogenesis in the dental pulp is emulated on a three-channel microfluidic chip where dental pulp stem cells are seeded in fibrin hydrogel in the middle. <t>HUVECs</t> are seeded on the gel interface in the side channel, forming a monolayer that is sprouting into the gel. Here, the model is used for evaluating dentistry-related drugs and biomaterials.
Antibody Against Red Fluorescence Protein Rfp, supplied by Rockland Immunochemicals, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/red+fluorescent+protein+rfp/Anti-rfp/pmc12722035-65-8-16
Average 98 stars, based on 1 article reviews
antibody against red fluorescence protein rfp - by Bioz Stars, 2026-09
98/100 stars
  Buy from Supplier

94
AcceGen Biotechnology skbr3 adenocarcinoma cells red fluorescent protein rfp
Sketch of a tooth injury where the highly vascularized dental pulp is exposed. Angiogenesis in the dental pulp is emulated on a three-channel microfluidic chip where dental pulp stem cells are seeded in fibrin hydrogel in the middle. <t>HUVECs</t> are seeded on the gel interface in the side channel, forming a monolayer that is sprouting into the gel. Here, the model is used for evaluating dentistry-related drugs and biomaterials.
Skbr3 Adenocarcinoma Cells Red Fluorescent Protein Rfp, supplied by AcceGen Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/red+fluorescent+protein+rfp/SK-BR-3/pm41634507-78-1-24
Average 94 stars, based on 1 article reviews
skbr3 adenocarcinoma cells red fluorescent protein rfp - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier

96
Rockland Immunochemicals rabbit anti red fluorescent protein rfp
Sketch of a tooth injury where the highly vascularized dental pulp is exposed. Angiogenesis in the dental pulp is emulated on a three-channel microfluidic chip where dental pulp stem cells are seeded in fibrin hydrogel in the middle. <t>HUVECs</t> are seeded on the gel interface in the side channel, forming a monolayer that is sprouting into the gel. Here, the model is used for evaluating dentistry-related drugs and biomaterials.
Rabbit Anti Red Fluorescent Protein Rfp, supplied by Rockland Immunochemicals, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/red+fluorescent+protein+rfp/Anti-mCherry+Antibody+Pre-Adsorbed/pm41353290-122-23-31
Average 96 stars, based on 1 article reviews
rabbit anti red fluorescent protein rfp - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier

98
Rockland Immunochemicals rabbit anti red fluorescence protein
Sketch of a tooth injury where the highly vascularized dental pulp is exposed. Angiogenesis in the dental pulp is emulated on a three-channel microfluidic chip where dental pulp stem cells are seeded in fibrin hydrogel in the middle. <t>HUVECs</t> are seeded on the gel interface in the side channel, forming a monolayer that is sprouting into the gel. Here, the model is used for evaluating dentistry-related drugs and biomaterials.
Rabbit Anti Red Fluorescence Protein, supplied by Rockland Immunochemicals, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/red+fluorescent+protein+rfp/Anti-rfp/pm41327464-81-8-15
Average 98 stars, based on 1 article reviews
rabbit anti red fluorescence protein - by Bioz Stars, 2026-09
98/100 stars
  Buy from Supplier

Image Search Results


Sketch of a tooth injury where the highly vascularized dental pulp is exposed. Angiogenesis in the dental pulp is emulated on a three-channel microfluidic chip where dental pulp stem cells are seeded in fibrin hydrogel in the middle. HUVECs are seeded on the gel interface in the side channel, forming a monolayer that is sprouting into the gel. Here, the model is used for evaluating dentistry-related drugs and biomaterials.

Journal: Materials Today Bio

Article Title: A microfluidic model of human dental pulp angiogenesis for preclinical drug and biomaterial testing

doi: 10.1016/j.mtbio.2026.102776

Figure Lengend Snippet: Sketch of a tooth injury where the highly vascularized dental pulp is exposed. Angiogenesis in the dental pulp is emulated on a three-channel microfluidic chip where dental pulp stem cells are seeded in fibrin hydrogel in the middle. HUVECs are seeded on the gel interface in the side channel, forming a monolayer that is sprouting into the gel. Here, the model is used for evaluating dentistry-related drugs and biomaterials.

Article Snippet: Red fluorescent protein (RFP) human umbilical vein endothelial cells (HUVECs) (Angio Proteomie) were cultured to 90 % confluency in endothelial growth medium (Vasculife, Cell systems) in T75 culture flasks precoated with 0.2 % gelatine (Sigma) for 1 h at 37 °C.

Techniques:

A) Angiogenic sprouts from HUVECs stained with CD31 (red) growing in fibrin hydrogel containing different concentrations of dental pulp stem cells. Scale bars: 200 μm. B). Quantification of total vessel length (μm), vessel area fraction (%), branch point count and segment count for the different dental pulp stem cell concentrations. Each data point represents one chip analysed in four distinct regions. Data presented as mean ± SD (∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001). (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)

Journal: Materials Today Bio

Article Title: A microfluidic model of human dental pulp angiogenesis for preclinical drug and biomaterial testing

doi: 10.1016/j.mtbio.2026.102776

Figure Lengend Snippet: A) Angiogenic sprouts from HUVECs stained with CD31 (red) growing in fibrin hydrogel containing different concentrations of dental pulp stem cells. Scale bars: 200 μm. B). Quantification of total vessel length (μm), vessel area fraction (%), branch point count and segment count for the different dental pulp stem cell concentrations. Each data point represents one chip analysed in four distinct regions. Data presented as mean ± SD (∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001). (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)

Article Snippet: Red fluorescent protein (RFP) human umbilical vein endothelial cells (HUVECs) (Angio Proteomie) were cultured to 90 % confluency in endothelial growth medium (Vasculife, Cell systems) in T75 culture flasks precoated with 0.2 % gelatine (Sigma) for 1 h at 37 °C.

Techniques: Staining

A) Angiogenic sprouts from HUVECs stained with CD31 (red) growing in hydrogels with different fibrin concentrations. Scale bars: 100 μm. B). Quantification of total vessel length (μm), vessel area fraction (%), branch point count and segment count. Each data point represents one chip analysed for three distinct regions. Data presented as mean ± SD (∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001). (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)

Journal: Materials Today Bio

Article Title: A microfluidic model of human dental pulp angiogenesis for preclinical drug and biomaterial testing

doi: 10.1016/j.mtbio.2026.102776

Figure Lengend Snippet: A) Angiogenic sprouts from HUVECs stained with CD31 (red) growing in hydrogels with different fibrin concentrations. Scale bars: 100 μm. B). Quantification of total vessel length (μm), vessel area fraction (%), branch point count and segment count. Each data point represents one chip analysed for three distinct regions. Data presented as mean ± SD (∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001). (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)

Article Snippet: Red fluorescent protein (RFP) human umbilical vein endothelial cells (HUVECs) (Angio Proteomie) were cultured to 90 % confluency in endothelial growth medium (Vasculife, Cell systems) in T75 culture flasks precoated with 0.2 % gelatine (Sigma) for 1 h at 37 °C.

Techniques: Staining

A) Flow generation driven by hydrostatic pressure from using pipette tips containing different volumes. B) Angiogenic sprouts of HUVECs stained with CD31 (red) growing during static (left), contra-directional (middle) or co-directional flow (right) conditions. Scale bars: 100 μm. C). Quantification of total vessel length (μm), vessel area fraction (%), branch point count and segment count for the different hydrostatic pressures. Each data point represents one chip analysed for four distinct regions. Data presented as mean ± SD (∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001). (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)

Journal: Materials Today Bio

Article Title: A microfluidic model of human dental pulp angiogenesis for preclinical drug and biomaterial testing

doi: 10.1016/j.mtbio.2026.102776

Figure Lengend Snippet: A) Flow generation driven by hydrostatic pressure from using pipette tips containing different volumes. B) Angiogenic sprouts of HUVECs stained with CD31 (red) growing during static (left), contra-directional (middle) or co-directional flow (right) conditions. Scale bars: 100 μm. C). Quantification of total vessel length (μm), vessel area fraction (%), branch point count and segment count for the different hydrostatic pressures. Each data point represents one chip analysed for four distinct regions. Data presented as mean ± SD (∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001). (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)

Article Snippet: Red fluorescent protein (RFP) human umbilical vein endothelial cells (HUVECs) (Angio Proteomie) were cultured to 90 % confluency in endothelial growth medium (Vasculife, Cell systems) in T75 culture flasks precoated with 0.2 % gelatine (Sigma) for 1 h at 37 °C.

Techniques: Transferring, Staining

Maximum intensity projections of confocal z-stacks of angiogenic sprouts (A–D). A) Cross-section of angiogenic sprouts of HUVECs stained with CD31 (red), collagen IV (green) and dapi (blue). White arrows indicate collagen IV production by dental pulp stem cells. Scale bar: 50 μm. B) and C) angiogenic tip cells stained with CD31 (red), collagen IV (green) and dapi (blue). Scale bar: 40 μm. D) Cross-section of angiogenic sprouts with red fluorescent protein (RFP)-producing HUVECs (red) and dental pulp stem cells stained with vimentin (green). Scale bar: 7 μm. E) Angiogenic sprouts perfused with 1 μm fluorescent beads (green). Scale bar: 100 μm. F) Angiogenic sprouts perfused with 10 μm fluorescent beads (green). Scale bar: 100 μm. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)

Journal: Materials Today Bio

Article Title: A microfluidic model of human dental pulp angiogenesis for preclinical drug and biomaterial testing

doi: 10.1016/j.mtbio.2026.102776

Figure Lengend Snippet: Maximum intensity projections of confocal z-stacks of angiogenic sprouts (A–D). A) Cross-section of angiogenic sprouts of HUVECs stained with CD31 (red), collagen IV (green) and dapi (blue). White arrows indicate collagen IV production by dental pulp stem cells. Scale bar: 50 μm. B) and C) angiogenic tip cells stained with CD31 (red), collagen IV (green) and dapi (blue). Scale bar: 40 μm. D) Cross-section of angiogenic sprouts with red fluorescent protein (RFP)-producing HUVECs (red) and dental pulp stem cells stained with vimentin (green). Scale bar: 7 μm. E) Angiogenic sprouts perfused with 1 μm fluorescent beads (green). Scale bar: 100 μm. F) Angiogenic sprouts perfused with 10 μm fluorescent beads (green). Scale bar: 100 μm. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)

Article Snippet: Red fluorescent protein (RFP) human umbilical vein endothelial cells (HUVECs) (Angio Proteomie) were cultured to 90 % confluency in endothelial growth medium (Vasculife, Cell systems) in T75 culture flasks precoated with 0.2 % gelatine (Sigma) for 1 h at 37 °C.

Techniques: Staining

A) Maximum projections of confocal z-stacks showing growth of angiogenic sprouts from red fluorescent protein (RFP) producing HUVECs (red) monitored live over 3 days. Scale bars: 200 μm. B) Quantification of total vessel length (μm), mean segment length (μm), vessel area fraction (%), mean segment diameter (μm). Each data point represents one chip analysed for four distinct regions. Data presented as mean ± SD (∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001). (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)

Journal: Materials Today Bio

Article Title: A microfluidic model of human dental pulp angiogenesis for preclinical drug and biomaterial testing

doi: 10.1016/j.mtbio.2026.102776

Figure Lengend Snippet: A) Maximum projections of confocal z-stacks showing growth of angiogenic sprouts from red fluorescent protein (RFP) producing HUVECs (red) monitored live over 3 days. Scale bars: 200 μm. B) Quantification of total vessel length (μm), mean segment length (μm), vessel area fraction (%), mean segment diameter (μm). Each data point represents one chip analysed for four distinct regions. Data presented as mean ± SD (∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001). (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)

Article Snippet: Red fluorescent protein (RFP) human umbilical vein endothelial cells (HUVECs) (Angio Proteomie) were cultured to 90 % confluency in endothelial growth medium (Vasculife, Cell systems) in T75 culture flasks precoated with 0.2 % gelatine (Sigma) for 1 h at 37 °C.

Techniques:

A) Schematic sketch of treatment schedule for day 1. B) Maximum projections of confocal stacks of HUVECs (red, CD31) treated on day 1 and fixed on day 4. Scale bars: 200 μm. C) Quantification of cell death %, LDH release and fold increase in vessel area fraction and vessel length after treatment. Each data point represents one chip analysed for three distinct regions. Data presented as mean ± SD (∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001). (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)

Journal: Materials Today Bio

Article Title: A microfluidic model of human dental pulp angiogenesis for preclinical drug and biomaterial testing

doi: 10.1016/j.mtbio.2026.102776

Figure Lengend Snippet: A) Schematic sketch of treatment schedule for day 1. B) Maximum projections of confocal stacks of HUVECs (red, CD31) treated on day 1 and fixed on day 4. Scale bars: 200 μm. C) Quantification of cell death %, LDH release and fold increase in vessel area fraction and vessel length after treatment. Each data point represents one chip analysed for three distinct regions. Data presented as mean ± SD (∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001). (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)

Article Snippet: Red fluorescent protein (RFP) human umbilical vein endothelial cells (HUVECs) (Angio Proteomie) were cultured to 90 % confluency in endothelial growth medium (Vasculife, Cell systems) in T75 culture flasks precoated with 0.2 % gelatine (Sigma) for 1 h at 37 °C.

Techniques:

A) Schematic sketch of treatment schedule for day 3. B) Maximum projections of confocal stacks of HUVECs (red, CD31) treated on day 3 and fixed on day 6. Scale bars: 200 μm. C) Quantification of cell death (in %), LDH release, fold increase in vessel area fraction and vessel length after treatment. Each data point represents one chip analysed for three distinct regions. Data presented as mean ± SD (∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001). (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)

Journal: Materials Today Bio

Article Title: A microfluidic model of human dental pulp angiogenesis for preclinical drug and biomaterial testing

doi: 10.1016/j.mtbio.2026.102776

Figure Lengend Snippet: A) Schematic sketch of treatment schedule for day 3. B) Maximum projections of confocal stacks of HUVECs (red, CD31) treated on day 3 and fixed on day 6. Scale bars: 200 μm. C) Quantification of cell death (in %), LDH release, fold increase in vessel area fraction and vessel length after treatment. Each data point represents one chip analysed for three distinct regions. Data presented as mean ± SD (∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001). (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)

Article Snippet: Red fluorescent protein (RFP) human umbilical vein endothelial cells (HUVECs) (Angio Proteomie) were cultured to 90 % confluency in endothelial growth medium (Vasculife, Cell systems) in T75 culture flasks precoated with 0.2 % gelatine (Sigma) for 1 h at 37 °C.

Techniques: